Patents Examined by Melissa Javier
-
Patent number: 9693953Abstract: The present invention provides novel pharmaceutical compositions containing triphenylethylene derivative compounds, and methods of using the composition for treatment of symptoms associated with atrophic vaginitis. The pharmaceutical compositions are prepared for the vaginal administration of triphenylethylene derivative compounds in single or combination therapies. Preferably, the triphenylethylene derivative is tamoxifen.Type: GrantFiled: June 4, 2007Date of Patent: July 4, 2017Inventors: Janet A. Chollet, Fred H. Mermelstein, Bernadette Klamerus
-
Patent number: 9693557Abstract: Compositions (feeding deterrent/repellent for Halyomorpha halys) containing at least two compounds selected from tridecane, E-2-decenal, isolongifolanone, isolongifolenone, and at least one isolongifolenone analog having the following formula: wherein R1 is hydrogen, an oxygen, a C1-10 alcohol, aldehyde, alkyl, ether, or esters of said alcohol with a C1-10 saturated or unsaturated, straight or branched acid and R2 is hydrogen, an oxygen, a C1-10 alcohol, aldehyde, alkyl, ether, or esters of said alcohol with a C1-10 saturated or unsaturated, straight or branched acid; optionally there is a double bond between carbons 5 and 6 and R2 is hydrogen; and optionally a carrier or carrier material. Also methods for deterring feeding/repelling Halyomorpha halys involving treating an object or area with a Halyomorpha halys deterring feeding/repelling effective amount of at least one compound selected from the above compounds.Type: GrantFiled: March 24, 2016Date of Patent: July 4, 2017Assignee: The United States of America, as Represented by the Secretary of AgricultureInventors: Aijun Zhang, Christina Harris, Tracy C. Leskey
-
Patent number: 9675710Abstract: The present invention relates to a lipid nanoparticle system comprising a lipid component, a cationic surfactant, a non-ionic surfactant, a polysaccharide and, optionally, a positively charged peptide, useful for the release of pharmacologically active molecules, and especially for transfecting genetic material into cells and/or tissues. It also relates to methods for obtaining nanoparticles, to pharmaceutical compositions comprising it, as well as to the use thereof in gene therapy.Type: GrantFiled: July 27, 2010Date of Patent: June 13, 2017Assignee: UNIVERSIDAD DEL PAIS VASCOInventors: Alicia Rodriguez Gascôn, Maria Angeles Solinís Aspíazu, Ana Del Pozo Rodriguez, Diego Delgado San Vicente, José Luis Pedraz Mu{umlaut over (n)}oz
-
Patent number: 9675570Abstract: The present disclosure provides solid compositions comprising a stabilized salt of aminocarboxylic acid. Pharmaceutical compositions comprising [(1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl]acetic acid monobenzenesulfonate in combination with appropriate additives are also provided.Type: GrantFiled: November 25, 2014Date of Patent: June 13, 2017Assignee: DAIICHI SANKY COMPANY, LIMITEDInventors: Shinichiro Tajiri, Masami Takemura, Shinji Yoshinaga
-
Patent number: 9642939Abstract: The present invention is directed to a novel cement powder comprising an organic component consisting of one or more biocompatible and bioresorbable polymers and an inorganic component consisting of one or more calcium phosphate compounds. The invention also relates to the apatitic CPC resulting from the mixing of said cement powder with a liquid phase and setting.Type: GrantFiled: August 23, 2007Date of Patent: May 9, 2017Assignees: GRAFTYS, UNIVERSITE DE NANTESInventors: Ibrahim Khairoun, Pierre Weiss, Jean-Michel Bouler
-
Patent number: 9561307Abstract: Disclosed are tissue graft compositions made of particles having different densities, methods of making these compositions, and methods of using these compositions for promoting tissue restoration in a patient.Type: GrantFiled: May 14, 2015Date of Patent: February 7, 2017Assignee: ACell, Inc.Inventors: Rodney W. Bosley, Jr., Clay Fette, Robert S. Tullius
-
Patent number: 9561179Abstract: The invention relates to a pharmaceutical composition comprising a plurality of controlled-release coated microparticles each comprising a floating core, on the surface of which is deposited a layer containing at least one active principle, said layer being covered with a controlled-release coating, characterized by the fact that said floating core is composed of cellulose acetate phthalate and has an apparent density of less than or equal to 0.6 g/mL and said coated microparticles have a density of less than or equal to 0.7 g/mL.Type: GrantFiled: May 28, 2010Date of Patent: February 7, 2017Assignee: FLAMEL IRELAND LIMITEDInventors: Catherine Castan, Philippe Caisse
-
Patent number: 9561961Abstract: The present invention relates to a biocompatible injectable filler composition comprising calcium phosphate particles having a porosity of about 10% to about 90%, a BET surface area of about 1 m2/g to about 100 m2/g, and a mean particle size of about 1 micron to about 30 microns, a thermoreversible hydrophilic gelling agent, a carrier comprising water and an optional persistence enhancer and/or volumizing agent, and methods of its use to restore tissue volume and/or to smooth out tissue defects as in soft tissue or deep tissue augmentation.Type: GrantFiled: August 17, 2012Date of Patent: February 7, 2017Assignee: Pioneer Surgical Technology, Inc.Inventors: Stephen M. Capistron, Edward S. Ahn
-
Patent number: 9555157Abstract: A method of inducing hemostasis in a wound. A hemostatic product is applied to a wound. The hemostatic product includes at least one hemostasis component. The hemostatic product is retained with respect to the wound by positioning a hydrogel material at least partially over the hemostatic product. At least a portion of the hemostatic product is dissolved. Hemostasis is induced in the wound with the at least one hemostasis component. The hydrogel material is separated from the wound. Substantially all of the hemostatic product remains on the wound.Type: GrantFiled: November 12, 2014Date of Patent: January 31, 2017Assignee: St. Teresa Medical, Inc.Inventors: Curtis Olson, Tim Floyd, Phil Messina
-
Patent number: 9492404Abstract: Provided are electrokinetically-altered fluids (e.g., electrokinetically-altered gas-enriched fluids and solutions) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient for treating an inflammatory neurodegenerative condition or disease (e.g., a taupathy) or at least one symptom thereof. The electrokinetically-altered fluids or therapeutic compositions and methods include electrokinetically-altered ionic aqueous fluids optionally in combination with other therapeutic agents. Particular aspects provide for modulating phosphorylation of tau protein. Particular aspects provide for regulating or modulating intracellular signal transduction associated with said inflammatory responses by modulation of at least one of cellular membrane potential and/or conductance, membrane proteins such as membrane receptors, including but not limited to G-Protein Coupled Receptors (GPCR), and intercellular junctions (e.g.Type: GrantFiled: August 12, 2011Date of Patent: November 15, 2016Assignee: Revalesio CorporationInventors: Richard L. Watson, Anthony B. Wood, Gregory J. Archambeau
-
Patent number: 9456860Abstract: Provided is a flowable bioresorbable tissue dressing comprising a gas-forming porogen and a gel or gel-forming solution. Also provided is kits for preparing the above-described tissue dressing. Further provided are methods of treating a tissue site of a mammal with the above dressing. Also provided is a reduced pressure delivery system for applying a reduced pressure tissue treatment to a tissue site.Type: GrantFiled: December 31, 2008Date of Patent: October 4, 2016Assignee: KCI Licensing, Inc.Inventor: Archel Ambrosio
-
Patent number: 9439985Abstract: The subject invention relates to the compositions for radiolabeling Diethylenetriaminepentaacetic Acid (DTPA)-dextran with Technetium-99m and for stabilizing the DTPA-dextran Cold Kit. The composition contains Stannous Chloride ions to reduce 99mTc-pertechnetate, Ascorbic Acid to reduce stannic ions to stannous ions to maintain a reducing environment, ?,?-Trehalose to add bulk and to stabilize the lyophilized composition without interfering with the radiochemical yield, and Glycine to transchelate Technetium-99m under highly acidic conditions to facilitate radiolabeling DTPA-dextran with high radiochemical purity. In addition, the invention pertains to methods for making and using the compositions. The reconstitution of the lyophilized composition by 99mTc-pertechnetate, resulting in radiolabeled 99mTc-DTPA-dextran in a composition between pH 3 to 4.Type: GrantFiled: September 27, 2013Date of Patent: September 13, 2016Assignee: Navidea Biopharmaceuticals, Inc.Inventors: Gerald Ross Magneson, Richard Cushman Orahood
-
Patent number: 9421162Abstract: Polymeric compositions containing additives having properties of emission and/or absorption of radiation in the long infrared region, and articles shaped therefrom are produced, including yarns and textile articles such as fabrics or knits; such additives include organic additives or inorganic fillers which have a capacity for absorption/emission of radiation in the infrared region, in a wavelength range of from 2 ?m to 20 ?m, and also a polymeric substrate, with the proviso that the inorganic fillers may be selected from among oxides, sulfates, carbonates, phosphates and silicates, and such inorganic fillers having an average particle size of less than 2 ?m.Type: GrantFiled: December 17, 2012Date of Patent: August 23, 2016Assignee: RHODIA POLIAMIDA E ESPECIALIDADES LTDAInventors: Thomas Canova, Dany Bizaroli De Mendonca, Tarcis Cordeiro Bastos
-
Patent number: 9415013Abstract: Disclosed herein are pharmaceutical compositions comprising a plurality of first beads each comprising: a core; a first layer comprising pilocarpine or a pharmaceutically acceptable salt thereof; and a second layer comprising a first polymer. Also disclosed are pharmaceutical compositions comprising a plurality of second beads each comprising: a core; and a first layer comprising tolterodine or a pharmaceutically acceptable salt thereof. Further disclosed are pharmaceutical formulations comprising: a) a plurality of the first beads; b) a plurality of the second beads; or c) a plurality of the first beads and a plurality of the second beads.Type: GrantFiled: April 1, 2011Date of Patent: August 16, 2016Assignee: TheraVida, Inc.Inventors: Mehdi Paborji, Robert V. Tuohy, III, Peter R. P. Freed, Roger S. Flugel
-
Patent number: 9403953Abstract: This invention relates to a cosmetic sponge and a method of providing a cosmetic sponge incorporating a non-denatured collagen and other additives for skin care, cleaning, and cosmetic application.Type: GrantFiled: October 2, 2012Date of Patent: August 2, 2016Assignee: Diversified Global Technologies, LLCInventor: Wayne Celia
-
Patent number: 9381189Abstract: A method of processing an active ingredient, the method comprising submitting a pharmaceutically active ingredient in the absence of excipients and/or additives to compression and shearing forces. The invention also relates to compositions comprising an active prepared by the method.Type: GrantFiled: December 8, 2010Date of Patent: July 5, 2016Assignee: VECTURA LIMITEDInventors: Matthew Michael James Green, Richard Michael Poole
-
Patent number: 9381162Abstract: A method for forming micro-particles is provided. The method includes the steps of: —providing a first solution which includes at least an anion; —providing a second solution which includes at least a cation; —mixing the first solution with the second solution in presence of at least a first compound for forming porous templates, wherein the porous templates are formed by precipitation of a salt which includes the anion and the cation and wherein the first compound is at least partially incorporated in the porous templates; and—at least partially cross-linking the first compound in the porous templates.Type: GrantFiled: July 14, 2008Date of Patent: July 5, 2016Assignee: CC-Ery GmbHInventors: Hans Bäumler, Radostina Georgieva
-
Patent number: 9364412Abstract: The compositions and methods disclosed herein pertain to the manufacture and use of hydrogels. The disclosed compositions and methods pertain to hydrogels capable of induction by a variety of methodologies, such as by pH, salt and/or mixing. Such hydrogels are capable of self- or co-assembly and while doing so, may entrap a variety of bioactive agents in their native form, such as proteins, DNA, RNA and the like. The hydrogels of the present invention also demonstrate rapid sheer-responsiveness. The hydrogels of the present invention are biodegradable, biocompatible and useful as a biomaterial or drug-delivery device.Type: GrantFiled: November 14, 2006Date of Patent: June 14, 2016Assignees: University of Utah Research Foundation, THE JOHNS HOPKINS UNIVERSITYInventors: Yihua Bruce Yu, Sivakumar Ramachandran, Yiider Tseng
-
Patent number: 9358200Abstract: Hydrophilic N-acylamino acid, N-acyl dipeptide, and N-acyl tripeptide substituted silanes are prepared which can be utilized as reactive surface treatments for particles of pigments, minerals, and fillers. These treated particles form stable dispersions in the aqueous phase of oil-in-water mixtures that are suitable for cosmetic applications. The treated particles may also be used in pressed powder and color cosmetic formulations.Type: GrantFiled: September 23, 2011Date of Patent: June 7, 2016Assignee: Gelest Technologies, Inc.Inventors: Barry C. Arkles, Jane C. Hollenberg, Youlin Pan
-
Patent number: 9351942Abstract: The invention provides a patch and a patch preparation having an adhesive layer with a high adhesive force, wherein the hydrophobic adhesive layer does not bloom even when an organic fluid component having high polarity is contained therein. The patch contains a support and an adhesive layer on at least one surface of the support, wherein the adhesive layer contains a synthetic rubber having a viscosity average molecular weight of 1,700,000-6,500,000, an organic fluid component having high polarity, a tackifier, and magnesium aluminometasilicate. In the patch preparation, the above-mentioned adhesive layer further contains a drug.Type: GrantFiled: February 1, 2012Date of Patent: May 31, 2016Assignee: Nitto Denko CorporationInventors: Masato Nishimura, Yoshihiro Iwao, Katsuhiro Okada, Kensuke Matsuoka